Propafenone in complex anti-recurrent therapy of persistent atrial fibrillation

Effectiveness and safety of Class IС antiarrhythmic agent, propafenone (Propanorm, PRO. MED. CS Praha a.s., Czech Republic), was studied inpatients with persistent atrial fibrillation (PAF) after sinus rhythm conversion, during long-term ant-recurrent treatment. The study included 30 men and women;...

Full description

Saved in:
Bibliographic Details
Main Authors: V. V. Skibitsky, E. A. Kudryashov, A. V. Fendrikova, N. A. Spiropulos
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2007-08-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/2186
Tags: Add Tag
No Tags, Be the first to tag this record!